2 different filers disclosed STE within 90 days. Disclosed 32 days after the transaction; reported as an official range, not an exact amount.
Traded Mar 5, 2026 · Filed Mar 6, 2026
A board member of Steris sold $735K of Steris shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$734,877
Shares × reported transaction price
29 days after results of Feb 4, 2026, 67 days before results of May 11, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $238.51 on Mar 5, 2026, 14% above its 52-week low and 11% below its high, after a 9% drop over the previous 30 trading days
52-week range $208.55 (Apr 8, 2025) to $268.65 (Jan 16, 2026), 50% of the way up, from 251 adjusted closes. 30 trading days earlier: $261.18 on Jan 21, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -3.8% | -1.4% | -2.5% |
| 30 days | -1.2% | -0.3% | -0.8% |
| 90 days | -7.8% | +9.0% | -16.8% |
| 180 days | -4.1% | +12.9% | -17.0% |
Past results only. Not a forecast.
2 different filers disclosed STE within 90 days. Disclosed 32 days after the transaction; reported as an official range, not an exact amount.
2 different filers disclosed STE within 90 days. Disclosed 27 days after the transaction; reported as an official range, not an exact amount.
Derivative exercise or conversion — not an open-market buy.